Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2011 · 10-Q
Revenue$2.85B$2.85B+10.0% vs Q2 2010 Net Income$523.40M$523.40M+120.6% vs Q2 2010 EPS Diluted$1.36$1.36+138.6% vs Q2 2010 Gross Profit$1,161,000,000+10.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$354,700,000+25.0% Free Cash Flowderived$301,000,000+32.4% Margins · derivedGross margin40.7%+0.3 pt vs Q2 2010
Operating margin9.3%−2.2 pt vs Q2 2010
Net margin18.3%+9.2 pt vs Q2 2010
ended Jul 2, 2011 · filed Aug 5, 2011 · 34 d after period end